New Report Projects Growth of Neurological Biomarkers Market in 2025
The Neurological Biomarkers Market for Alzheimer's and Parkinson's disease was valued at $3,958.5 million in 2017, and is expected to reach $8,579.9 million by 2025, registering a CAGR of 10.1% from 2018-2025. Neurodegenerative diseases such as Alzheimer's and Parkinson's are characterized by gradual loss of cognitive function, dementia, and problems with movements. Currently, research activities focused on biomarkers in the field of neurodegenerative diseases is significantly important, owing to surge in incidence of Alzheimer's and Parkinson's diseases worldwide.
View full press release